Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis

被引：0
|
作者：
Dantong Sun
Yan Zhu
Han Zhao
Tiantian Bian
Tianjun Li
Kewei Liu
Lizong Feng
Hong Li
Helei Hou
机构：
[1] The Affiliated Hospital of Qingdao University,Precision Medicine Center of Oncology
[2] The Municipal Hospital of Qingdao,Department of Medical Oncology
[3] The Affiliated Hospital of Qingdao University,Department of Pathology
[4] The Affiliated Hospital of Qingdao University,Breast Disease Center
[5] Qingdao University,Department of General Surgery
[6] Qingdao Eighth People’s Hospital,State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital
[7] Shanghai Jiaotong University School of Medicine,undefined
来源：
Cellular Oncology | 2021年 / 44卷
关键词：
Lung adenocarcinoma; ARID1A; Nomogram; Metastasis; Akt;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1019 / 1034
页数：15
相关论文
共 50 条
  • [1] Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis
    Sun, Dantong
    Zhu, Yan
    Zhao, Han
    Bian, Tiantian
    Li, Tianjun
    Liu, Kewei
    Feng, Lizong
    Li, Hong
    Hou, Helei
    [J]. CELLULAR ONCOLOGY, 2021, 44 (05) : 1019 - 1034
  • [2] Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma
    Xu, Ning
    Wang, Lili
    Sun, Ping
    Xu, Suyang
    Fu, Shiping
    Sun, Zhihua
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (03) : 875 - 881
  • [3] Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinoma
    Kim, Min Jong
    Gu, Mi Jin
    Chang, Hee-Kyung
    Yu, Eunsil
    [J]. HISTOPATHOLOGY, 2015, 66 (04) : 508 - 516
  • [4] Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer
    Zhu, Yi Ping
    Sheng, Li Li
    Wu, Jing
    Yang, Mo
    Chen, Xian Feng
    Wu, Ning Ni
    Ye, Xiao Bing
    Cai, Juan
    Wang, Lu
    Shen, Qian
    Wu, Jian Qiu
    [J]. HUMAN PATHOLOGY, 2018, 78 : 28 - 35
  • [5] Loss of ARID1A expression is associated with poor prognosis in non-small cell lung cancer
    Jang, Si-Hyong
    Lee, Ji-Hye
    Lee, Hyun Ju
    Cho, Hyundeuk
    Ahn, Hyein
    Song, In Hag
    Oh, Mee-Hye
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [6] Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma
    He, Fei
    Li, Jie
    Xu, JianFeng
    Zhang, Sheng
    Xu, YaPing
    Zhao, WenXiu
    Yin, ZhenYu
    Wang, XiaoMin
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [7] Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma
    Fei He
    Jie Li
    JianFeng Xu
    Sheng Zhang
    YaPing Xu
    WenXiu Zhao
    ZhenYu Yin
    XiaoMin Wang
    [J]. Journal of Experimental & Clinical Cancer Research, 34
  • [8] Loss of ARID1A Expression Predicts Worse Overall Survival in Patients with Resected Pancreatic Adenocarcinoma and Is Associated with Inactivating Mutations of the ARID1A Gene
    da Silva, Annacarolina
    Morales-Oyarvide, Vicente
    Rubinson, Douglas A.
    Kozak, Margaret M.
    Wang, Wenjia
    Agostini-Vulaj, Diana
    Huber, Aaron
    Chang, Daniel T.
    Clancy, Thomas E.
    Hezel, Aram F.
    Ogino, Shuji
    Wolpin, Brian M.
    Nowak, Jonathan A.
    [J]. MODERN PATHOLOGY, 2018, 31 : 675 - 675
  • [9] Loss of ARID1A Expression Predicts Worse Overall Survival in Patients with Resected Pancreatic Adenocarcinoma and Is Associated with Inactivating Mutations of the ARID1A Gene
    da Silva, Annacarolina
    Morales-Oyarvide, Vicente
    Rubinson, Douglas A.
    Kozak, Margaret M.
    Wang, Wenjia
    Agostini-Vulaj, Diana
    Huber, Aaron
    Chang, Daniel T.
    Clancy, Thomas E.
    Hezel, Aram F.
    Ogino, Shuji
    Wolpin, Brian M.
    Nowak, Jonathan A.
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 675 - 675
  • [10] High expression of NCOA5 promotes the proliferation of lung adenocarcinoma cells and predicts the poor prognosis in lung adenocarcinoma
    Su, R. L.
    Sha, R. L.
    Sun, D. J.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 18 - 19
12345